Procept BioRobotics Q2 net loss widens to $26.86 million; revenue rises 19% to $94.5 million - PRCT News | RalliesProcept BioRobotics Q2 net loss widens to $26.86 million; revenue rises 19% to $94.5 million
P
PRCT• Q2 revenue rises, net loss widens
- Procept BioRobotics posted Q2 revenue of $94.5 million, up 19% from the prior-year period; GAAP net loss widened to $26.9 million.
- Gross margin edged up 1 percentage point to 66%, due to higher U.S. system and consumable pricing and a $2.9 million tariff refund.
- U.S. procedures climbed about 21% to over 13,100; the company delivered 65 U.S. HYDROS systems, including 14 replacements.
- Average selling price for new U.S. HYDROS systems was about $495,000; handpiece ASP rose 11% to about $3,550.
- Maintained full-year revenue guidance of $390 million-$410 million; lifted U.S. procedure outlook to 54,000-56,000.
•
